Joseph R. Shaw: Join The Annual CanVECTOR National Thrombosis Seminar on Precision in DOAC Reversal
Joseph R. Shaw, Director of Research+ Program at Ottawa Department of Medicine, EHJ-CVP Associate Editor at European Heart Journal, shared on LinkedIn about a recent article published in JTH, adding:
”In my role as Chair of the CanVECTOR National Thrombosis Seminars, I’m pleased to share the final seminar of our 2025–2026 academic year.
Join us for: Working Towards Precision in DOAC Reversal Through Harnessing the Power of a National, Trainee-Led Network in the UK
Monday, June 8, 2026 | 12:00–12:45 p.m. ET
Featuring Richard Buka, PhD, MBChB, University of Birmingham.
This session will examine what ‘precision’ in DOAC reversal looks like in real-world practice, including not only the choice of reversal strategy, such as andexanet alfa, idarucizumab, and 4-factor prothrombin complex concentrate (4F-PCC/PCC), but also administration logistics, timing, dosing, patient selection, governance, and the potential role of urgent DOAC drug levels.
The discussion will draw on insights from the HaemSTAR trainee-led network and the JTH paper, ‘A UK-wide analysis of 2265 patients receiving a reversal agent for direct oral anticoagulant-associated bleeding.’
Moderator: Joseph R. Shaw, MD MSc FRCPC DRCPSC (Ottawa Hospital Research Institute)
A QandA session will follow the presentation.”
Title: A UK-wide analysis of 2265 patients receiving a reversal agent for direct oral anticoagulant-associated bleeding
Authors: HaemSTAR Collaborators
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026